Print

Siemens Healthcare Diagnostics Recalls MicroScan Synergies Plus® and RapID/S plus Gram Negative Panels  
9/17/2013 11:16:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthcare Diagnostics (NYSE:SI) has issued a voluntary recall of its MicroScan Synergies plus® Negative and rapID/S plus Negative panels. These panels are used for determining antimicrobial susceptibility and/or identification for gram-negative bacteria. An internal investigation has confirmed an increase in false susceptible and false intermediate misreads for imipenem and/or meropenem when read rapidly (< 16 hours) on the MicroScan® WalkAway Microbiology System¹. The investigation determined that no other antimicrobial agent results are affected. Siemens has notified the FDA of this action.

Help employers find you! Check out all the jobs and post your resume.

//-->